The study concerns the use of Nefecon among adult patients with primary IgA nephropathy
News
Evgen releases data from SFX-01 trial
The study is specifically analysing the company’s new enteric coated tablet formation of the drug
CymaBay begins phase 3 liver disease study
IDEAL study aims to determine the impact of seladelpar on alkaline phosphatase levels
CNX acquires four cancer drugs from Clinigen
The purchased therapies concerned are Cardioxane, Totect, Ethyol and Savene
Novartis’ remibrutinib shows promise for patients with CSU
Highly selective inhibitor therapy treats patients with chronic spontaneous urticaria
Atai Life delivers results from PCN-101 study
Data supports further exploration of candidate as a rapid-acting anti-depressant for home use
Green light for one of Europe’s largest life sciences campus
UBS Asset Management and Reef Group secure approval for the Stevenage-based facility
AlzeCure delivers positive NeuroRestore candidate results
The therapy reaches and activates areas of the brain that are central to cognitive enhancement
Astex reveals partnership with MSD
The partnership will establish small molecule candidates with a view to treating cancer
Amarin’s Vazkepa gets green light from SMC
Treatment will help reduce the risk of heart attacks and strokes for patients across Scotland
Infex candidate nominated for COV-X programme
Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response
Two AstraZeneca therapies accepted in Scotland
Tezspire is a drug for severe asthma and Forxiga is used to treat chronic heart failure
Taiho begins latest non-small cell lung cancer trial
A combination of zipalertinib and chemotherapy will be evaluated as a treatment for adults
Evox Therapeutics reaches gene therapy agreement
Partnership with Icahn School of Medicine will involve developing exoAAV vectors for heart disease patients
First patient dosed in AskBio’s AB-1003 trial
Research is evaluating the company’s novel investigational FKRP gene replacement therapy
